Malignant lymphomas in transplantation patients.
D000293:Adolescent; D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000276:immunology; D005260:Female; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D016030:Kidney Transplantation; D008113:Liver Neoplasms / Q000276:immunology; D008223:Lymphoma / Q000276:immunology*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000276:immunology; D008228:Lymphoma, Non-Hodgkin / Q000276:immunology; D008297:Male; D008479:Mediastinal Neoplasms / Q000276:immunology; D009362:Neoplasm Metastasis; D010954:Plasmacytoma / Q000276:immunology; D011241:Prednisone / Q000627:therapeutic use; D013156:Splenectomy; D013934:Thymectomy; D013964:Thyroid Neoplasms / Q000276:immunology; D014181:Transplantation Immunology; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D001379:Azathioprine; D011241:Prednisone